Whole Blood Gene Expression Reveals Specific Transcriptome Changes in Neonatal Encephalopathy

Area of Science:

• Neonatal medicine
• Genomics
• Neuroscience

Background:

• Hypothermic neuroprotection effectiveness varies due to clinical heterogeneity in neonatal encephalopathy.
• Improved disease stratification is crucial for developing tailored neuroprotective therapies.

Purpose of the Study:

• To investigate if whole blood gene expression analysis can identify specific transcriptome profiles in neonatal encephalopathy.
• To explore potential biomarkers for disease stratification.

Main Methods:

• Next-generation sequencing of whole blood RNA from 12 neonatal encephalopathy cases and 6 healthy controls.
• Identification of differentially expressed genes and pathway analysis.
• Comparison of neonatal encephalopathy gene expression with sepsis-related RNA profiles.

Main Results:

• Identified 950 statistically significant genes distinguishing neonatal encephalopathy from controls.
• Key pathways implicated include axonal guidance signaling, granulocyte adhesion, IL-12 signaling, and HIF-1α signaling.
• Found only 137 overlapping genes between neonatal encephalopathy and bacterial sepsis gene sets.

Conclusions:

• Neonatal encephalopathy exhibits unique gene expression profiles compared to healthy and septic neonates.
• Gene expression patterns hold potential for stratifying disease severity.
• Transcriptome analysis may pave the way for personalized neuroprotective strategies in neonatal encephalopathy.